Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Empirical treatment

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    43 result(s) found for: Empirical treatment. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2012-003067-22 Sponsor Protocol Number: PRISTINE Start Date*: 2012-11-19
    Sponsor Name:LUMC
    Full Title: Pneumonia treated with rifampicine attenuates inflammation
    Medical condition: Community acquired pneumonia CURB-65 class >1
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004862 10010120 Community acquired pneumonia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-008382-35 Sponsor Protocol Number: AIFA - FARM07YPBW Start Date*: 2010-04-08
    Sponsor Name:Azienda Ospedaliera di Perugia
    Full Title: Open , multicenter, randomized trial comparing two therapeutic approaches for the treatment of invasive fungal infections in neutropenic onco-hematologic patients.Empiric vs. ``presumptive`` (pree...
    Medical condition: opportunistic fungal infections in neutropenic onco-hematologic patients
    Disease: Version SOC Term Classification Code Term Level
    9.1 10017528 Fungal infectious disorders HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2016-000078-39 Sponsor Protocol Number: GEO-2014/01-HR Start Date*: 2016-05-25
    Sponsor Name:PLIVA Hrvatska d.o.o.
    Full Title: A prospective, multicentre, uncontrolled study of Geonistin vaginal tablets effectiveness with pharmacokinetic evaluation for unspecific and mixed vulvovaginal infections characterized by vaginal d...
    Medical condition: Unspecific and mixed vulvovaginal infections characterized by vaginal discharge.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: HR (Completed)
    Trial results: View results
    EudraCT Number: 2019-002569-37 Sponsor Protocol Number: APHP180584 Start Date*: 2020-05-13
    Sponsor Name:Assistance Publique Hôpitaux de Paris
    Full Title: Empirical steroids and/or antifungals in immunocompromised patients with acute respiratory failure from undetermined etiology: a multicenter double-blind randomized controlled trial
    Medical condition: immunocompromised patients with acute respiratory failure
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2009-015800-25 Sponsor Protocol Number: 810 Start Date*: 2010-01-19
    Sponsor Name:The Liverpool Heart & Chest Hospital NHS Trust
    Full Title: A pilot randomised control trial, in intensive care patients, comparing seven days versus two days treatment with empirical antibiotics to treat hospital acquired infection of unknown origin
    Medical condition: Healthcare associated infections This includes infections of the: • Skin and underneath the skin, including muscle - sometimes called ‘soft tissue’ • Urinary tract - including your kidneys or bladd...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2015-001566-26 Sponsor Protocol Number: BDG-ETHIC Start Date*: 2017-01-11
    Sponsor Name:AOU DI BOLOGNA POLICLINICO S.ORSOLA-MALPIGHI
    Full Title: A B-D-GLUCAN DRIVEN ANTIFUNGAL STEWARDSHIP APPROACH TO MANAGE EMPIRICAL THERAPY IN PATIENTS AT VERY HIGH RISK FOR INVASIVE CANDIDIASIS: A RANDOMIZED CONTROLLED TRIAL
    Medical condition: invasive candidiasis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004862 10064954 Invasive candidiasis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-000574-69 Sponsor Protocol Number: D9612L00076 Start Date*: 2006-04-07
    Sponsor Name:AstraZeneca A/S
    Full Title: Development of an algorithm for identification of responders to short term treatment with esomeprazol (Nexium) in primary care.
    Medical condition: acid related disease
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2010-023310-31 Sponsor Protocol Number: MagicBullet/COLMER Start Date*: 2011-02-07
    Sponsor Name:Consorcio de apoyo a la Investigación Biomédica en Red (CAIBER)
    Full Title: Ensayo clínico en fase IV aleatorizado, abierto, multicéntrico y de no inferioridad para comparar la seguridad y la eficacia de colistina iv. con meropenem iv. en el tratamiento de la neumonía asoc...
    Medical condition: Neumonía asociada a ventilación mecánica
    Disease: Version SOC Term Classification Code Term Level
    13 10052596 Neumonia nosocomial LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) IT (Completed) GR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-005021-13 Sponsor Protocol Number: MK-0991-044 Start Date*: 2015-04-03
    Sponsor Name:Merck & Co., Inc.
    Full Title: A Multicenter, Double-Blind, Randomized, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Versus (Amphotericin B) Liposome for Injection as Empirical Therapy in P...
    Medical condition: Empirical Therapy in Pediatric Patients
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2014-004628-23 Sponsor Protocol Number: M000507_6004 Start Date*: 2015-03-17
    Sponsor Name:Sanofi
    Full Title: Comparison of Teicoplanin and Vancomycin in Terms of Efficacy and Side Effect Profile During Initial Antibiotic Treatment of Febrile Neutropenic Patients at High Risk For Gram-Positive Infection: M...
    Medical condition: Neutropenic and febrile patients with hematological or solid tumors, who are at high risk for gram-positive bacterial infection.
    Disease: Version SOC Term Classification Code Term Level
    17.1 10021881 - Infections and infestations 10060945 Bacterial infection PT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2006-006210-14 Sponsor Protocol Number: GIMEMA01 Start Date*: 2007-07-12
    Sponsor Name:UNIVERSITA' DEGLI STUDI DI PERUGIA
    Full Title: PIPERACILLIN/TAZOBACTAM PLUS TIGECYCLINE VS. PIPERACILLIN/TAZOBACTAM ALONE AS EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIC CANCER PATIENTS : A PROSPECTIVE, RANDOMISED, MULTI-CENTRE, STUDY.
    Medical condition: Neutropenic, febrile cancer patients
    Disease: Version SOC Term Classification Code Term Level
    6.1 10004018 HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-020814-27 Sponsor Protocol Number: 65091-06093 Start Date*: 2012-05-10
    Sponsor Name:EORTC
    Full Title: Empirical versus pre-emptive (diagnostic-driven) antifungal therapy of patients treated for haematological malignancies or receiving an allogeneic stem cell transplant. A therapeutic open label pha...
    Medical condition: Invasive fungal infection in patients with hematological malignancies.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10017544 Fungemia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) NL (Completed) BE (Completed) CZ (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2006-001549-32 Sponsor Protocol Number: Caspofungin vs Amfotericina Start Date*: 2006-03-01
    Sponsor Name:A.I.E.O.P. - ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA
    Full Title: Prospectic, multicentric, randomized, controlled trial for the evaluation of efficacy of Caspofungin vs Amfotericina B liposomiale for the empirical treatment of the FUO in children neutropenic for...
    Medical condition: Neutropenia (neutrophil count <500/mm3 for at least 10 days persistent fever for at least 72-96 hours, refrectory to the traetment with wide spectrum antibiotic appropriate for high risk pa...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10029354 Neutropenia LLT
    Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-005032-34 Sponsor Protocol Number: MK-0991-058 Start Date*: 2015-02-27
    Sponsor Name:Merck & Co., Inc.
    Full Title: A Multicenter, Sequential-Panel, Open-Label, Noncomparative Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Caspofungin Acetate in Neonates and Infants Less Than 3 Months of ...
    Medical condition: Empirical therapy for fungal infections
    Disease:
    Population Age: Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2014-003558-15 Sponsor Protocol Number: M14-197 Start Date*: 2015-07-14
    Sponsor Name:AbbVie Deutschland GmbH & Co. KG
    Full Title: A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects with Active Psoriatic Arthritis Who Have an Inadequate Response to Methotrexate
    Medical condition: Psoriatic Arthritis
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004859 10037160 Psoriatic arthritis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) LV (Completed) HU (Completed) CZ (Completed) ES (Completed) BG (Completed)
    Trial results: View results
    EudraCT Number: 2016-001108-47 Sponsor Protocol Number: BARIFER Start Date*: 2016-05-29
    Sponsor Name:Fundació Hospital Universitari Vall Hebron-Institut de Recerca (VHIR)
    Full Title: Impact of eradication of asymptomatic bacteriuria on reducing the incidence of early infection in patients with periprosthetic femoral fractures requiring hip hemiarthroplasty
    Medical condition: Early infection in patients with periprosthetic femoral fracture
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2021-001840-83 Sponsor Protocol Number: SAGA Start Date*: 2022-04-26
    Sponsor Name:University Medical Center Utrecht
    Full Title: Short-course aminoglycosides as adjunctive treatment in adults with sepsis
    Medical condition: Patients admitted with sepsis of unknown origin, suspected urinary origin or suspected abdominal origin
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-016476-67 Sponsor Protocol Number: 780/09 Start Date*: 2009-03-23
    Sponsor Name:AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
    Full Title: treatment of healthcare-associated pneumonia: a prospective, multicenter study
    Medical condition: Pneumonia
    Disease: Version SOC Term Classification Code Term Level
    9.1 10004048 HLT
    9.1 10060946 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-002800-40 Sponsor Protocol Number: A1501073 Start Date*: 2006-02-09
    Sponsor Name:Pfizer Ltd
    Full Title: Prospective, Open-label, Comparative, Multicenter Study of Voriconazole Compared to Itraconazole for the Primary Prophylaxis of Invasive Fungal Infections (IFI) in Subjects with Allogeneic Hematopo...
    Medical condition: Prophylaxis against invasive fungal infection following allogeneic hematopoietic stem cell transplantation.
    Disease: Version SOC Term Classification Code Term Level
    8 10017533
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) CZ (Completed) ES (Completed) PT (Completed) GR (Completed)
    Trial results: View results
    EudraCT Number: 2014-001759-22 Sponsor Protocol Number: PGX401-11 Start Date*: 2015-07-24
    Sponsor Name:Laboratoire Innotech International
    Full Title: Assessment of the efficacy of POLYGYNAX® in the empirical treatment of infectious vaginitis International, multicentre, randomised, double-blind, parallel group study, comparative versus miconazole
    Medical condition: Patients presenting with abnormal vaginal discharge associated with other vaginal symptoms (i.e. vaginal burning and/or vaginal irritation and/or vaginal pain) clinically evoking infectious vaginit...
    Disease: Version SOC Term Classification Code Term Level
    18.0 10021881 - Infections and infestations 10046950 Vaginitis LLT
    18.0 10021881 - Infections and infestations 10046914 Vaginal infection PT
    18.0 10021881 - Infections and infestations 10001107 Acute vaginitis LLT
    18.0 10021881 - Infections and infestations 10029562 Non-specific vaginitis LLT
    18.0 10021881 - Infections and infestations 10062167 Vaginitis bacterial PT
    Population Age: Adults Gender: Female
    Trial protocol: FR (Completed) CZ (Completed) SK (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed May 21 14:31:51 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA